Internal Medicine, Gastroenterology · Pueblo, CO
NPI
1265477046
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1020 Lakeview Ave
Pueblo, CO, 81004
Phone (719) 557-3660
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
1,171 services
Medicare patients, 2024
531
Average age 71
Drug cost, 2024
$2.0M
3,994 prescriptions
Company payments, 2025
$518
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Camille G Azar was code 99214 (office e&m - established), 357 times for 230 patients. In total Camille G Azar billed 1,171 services in 36 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 357 | 230 | $93.57 | $33K |
| 43239 Upper GI Endoscopy | Facility | 200 | 185 | $71.03 | $14K |
| 99204 Office E&M - New | Office | 91 | 91 | $119.08 | $11K |
| 99213 Office E&M - Established | Office | 89 | 83 | $63.40 | $5,643 |
| 45385 Colonoscopy - Lesion Removal | Facility | 66 | 65 | $194.67 | $13K |
| 43248 Upper GI Endoscopy | Facility | 50 | 35 | $108.26 | $5,413 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 44 | 44 | $180.49 | $7,942 |
| 45378 Lower GI Endoscopy - Other | Facility | 40 | 40 | $122.46 | $4,898 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 29 | 29 | $179.92 | $5,218 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 27 | 25 | $3.58 | $96.74 |
| 45380 Lower GI Endoscopy - Other | Facility | 26 | 26 | $107.62 | $2,798 |
| 43235 Upper GI Endoscopy | Facility | 17 | 12 | $88.66 | $1,507 |
| 43246 Upper GI Endoscopy | Facility | 15 | 11 | $145.95 | $2,189 |
| 91200 Standard X-ray | Office | 14 | 13 | $21.39 | $299 |
| 43244 Upper GI Endoscopy | Facility | 13 | 13 | $169.95 | $2,209 |
By year: 2022 $129K for 1,298 services; 2023 $119K for 1,127 services; 2024 $121K for 1,171 services.
Medicare prescription drug claims, 2024
In 2024, the drug Camille G Azar prescribed most often to Medicare patients was Esomeprazole Magnesium, with 964 prescriptions and refills. In total Camille G Azar wrote 3,994 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Esomeprazole Magnesium Generic | 964 | 1,229 | 229 | $38K |
| Omeprazole Generic | 689 | 1,271 | 188 | $14K |
| Baclofen Generic | 308 | 401 | 69 | $3,533 |
| Linzess Linaclotide | 296 | 402 | 70 | $213K |
| Xifaxan Rifaximin | 158 | 158 | 29 | $509K |
| Furosemide Generic | 128 | 265 | 42 | $492 |
| Amiloride Hcl Generic | 127 | 165 | 29 | $1,244 |
| Rabeprazole Sodium Generic | 121 | 243 | 34 | $5,903 |
| Ursodiol Generic | 73 | 107 | 18 | $5,607 |
| Spironolactone Generic | 64 | 148 | 26 | $1,089 |
| Colesevelam Hcl Generic | 63 | 99 | 18 | $4,427 |
| Celecoxib Generic | 58 | 131 | 22 | $1,841 |
| Azathioprine Generic | 58 | 114 | 11 | $2,656 |
| Lubiprostone Generic | 47 | 79 | 16 | $6,380 |
| Lactulose Generic | 42 | 54 | 20 | $1,116 |
Brand drugs: 891 claims; generic drugs: 3,103 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Camille G Azar $518 ($518 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $300.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.